BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin J, Chen J, Peng F, Sun C, Lei Y, Chen G, Li G, Yin Y, Lin Z, Wu L, Li J, Liu W, Peng C, Xie X. Pharmacological activities and pharmacokinetics of liquiritin: A review. J Ethnopharmacol 2022;:115257. [PMID: 35395381 DOI: 10.1016/j.jep.2022.115257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Wu X, Zhong B, Liao Q, Wang X, Xie Y, He X. Review on the Diverse Biological Effects of Glabridin. Drug Des Devel Ther 2023;17:15-37. [PMID: 36647530 DOI: 10.2147/DDDT.S385981] [Reference Citation Analysis]
2 Han X, Yang Y, Zhang M, Li L, Xue Y, Jia Q, Wang X, Guan S. Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway. Drug Des Devel Ther 2022;16:4111-25. [PMID: 36483459 DOI: 10.2147/DDDT.S386805] [Reference Citation Analysis]
3 Li T, Li X, Zhang J, Yu Z, Gong F, Wang J, Tang H, Xiang J, Zhang W, Cai D. Chemical component analysis of the traditional Chinese medicine Guipi Tang and its effects on major depressive disorder at molecular level. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e12182] [Reference Citation Analysis]
4 Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics 2022;14:2135. [PMID: 36297570 DOI: 10.3390/pharmaceutics14102135] [Reference Citation Analysis]
5 Wang M, Zhang X, Chu Y, Li Z, Zuo L, Kang J, Cheng G, Sunzhi, Zhang X, Du S. Discovery of quality markers for Mailuoshutong Pill based on “spider web” mode of “Content-Pharmacokinetics-Pharmacology” network. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.104296] [Reference Citation Analysis]
6 Tang TJ, Wang X, Wang L, Chen M, Cheng J, Zuo MY, Gu JF, Ding R, Zhou P, Huang JL. Liquiritin inhibits H2 O2 -induced oxidative stress injury in H9c2 cells via the AMPK/SIRT1/NF-κB signaling pathway. J Food Biochem 2022;:e14351. [PMID: 35929638 DOI: 10.1111/jfbc.14351] [Reference Citation Analysis]
7 Molaei A, Molaei E, Sadeghnia H, Hayes AW, Karimi G. LKB1: An emerging therapeutic target for cardiovascular diseases. Life Sci 2022;306:120844. [PMID: 35907495 DOI: 10.1016/j.lfs.2022.120844] [Reference Citation Analysis]